University Of Medicine And Dentistry Of New Jersey

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Established
1970-01-01
Employees
-
Market Cap
-
Website
http://www.umdnj.edu/

LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma

Not Applicable
Terminated
Conditions
First Posted Date
2005-09-12
Last Posted Date
2009-12-11
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
64
Registration Number
NCT00161239
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor

Phase 3
Terminated
Conditions
First Posted Date
2005-09-12
Last Posted Date
2009-12-11
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
60
Registration Number
NCT00161200
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Acitretin and Etanercept in Psoriasis

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-09-12
Last Posted Date
2015-02-16
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
10
Registration Number
NCT00156247

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

First Posted Date
2005-09-12
Last Posted Date
2023-08-14
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
44
Registration Number
NCT00161213
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Central Jersey Oncology Group, New Brunswick, New Jersey, United States

๐Ÿ‡บ๐Ÿ‡ธ

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

CentraState Medical Center, Freehold, New Jersey, United States

and more 5 locations

Alefacept Mechanism of Action in Psoriasis

Phase 2
Completed
Conditions
First Posted Date
2005-09-08
Last Posted Date
2008-08-07
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
9
Registration Number
NCT00150982
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UMDNJ Clinical Research Center, New Brunswick, New Jersey, United States

Bexarotene With Narrow-Band UVB for Psoriasis

Phase 2
Completed
Conditions
First Posted Date
2005-09-08
Last Posted Date
2008-08-07
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
35
Registration Number
NCT00151008

Efalizumab for Eczema

Phase 2
Completed
Conditions
First Posted Date
2005-09-05
Last Posted Date
2008-08-07
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
10
Registration Number
NCT00146003
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UMDNJ Psoriasis Center of Excellence, New Brunswick, New Jersey, United States

Heart Rate and Blood Pressure Response During Exercise and Sexual Activity in Normotensive and Hypertensive Volunteers

First Posted Date
2005-09-02
Last Posted Date
2009-08-24
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
36
Registration Number
NCT00143988
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume

Completed
Conditions
First Posted Date
2005-09-02
Last Posted Date
2009-08-11
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
16
Registration Number
NCT00143858
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

Transitioning From Cyclosporine to Alefacept in Psoriasis

Phase 2
Completed
Conditions
First Posted Date
2005-09-02
Last Posted Date
2009-01-05
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
13
Registration Number
NCT00143806
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UMDNJ Clinical Research Center, New Brunswick, New Jersey, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath